Forbes Middle East recognized trailblazers in the healthcare sector for their outstanding contributions to advancing ...

Scottish patients placed at the heart of a multi-million pound study of weight-loss medicines. Scottish patients placed at the heart of a ...

The UK Government is funding a study which will involve 5,000 people from some of Scotland’s most deprived areas being given Wegovy injections.

Pfizer is suing over some unsolicited competition in its nearly $5 billion bid to buy the drugmaker Metsera. New York-based Pfizer said Friday after markets closed that it was suing Metsera and a ...

The lawsuit says Novo Nordisk’s offer for drug startup Metsera isn’t reasonably likely to be completed.

Risks and uncertainties include, among other things, risks and uncertainties related to the impact of Novo Nordisk’s proposal on the proposed acquisition; risks related to the satisfaction or waiver ...

Regulated Information Availability of the Fiscal 2025 Universal Registration Document Issy-les-Moulineaux, October 31, 2025 Sodexo’s Fiscal 2025 Universal Registration Document (URD) was filed with ...

This proprietary system employs specialized algorithms to identify early signs of litigation trends in federal litigation filings. Click here to learn more about Law.com Radar's new suit alerting and ...

Novo Nordisk has notified employees impacted by the drugmaker's job cuts in the vast majority of its locations although the ...

Denmark's Novo Nordisk launched a rival bid for U.S. obesity biotech firm Metsera on Thursday, hijacking an offer from Pfizer ...

Novo’s bid uses an unusual structure allowing Metsera investors to get most of the money upfront when the deal is signed.

Novo Nordisk, a leader in weight-loss drugs, is offering $6 billion up front with the potential for later milestone payments ...